Machine learning reveals why cancer trials fall short in real-world patients

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy.

PROs Support Practice-Changing RUBY Trial in Endometrial Cancer

The buzz created by two phase III studies testing immunotherapy in advanced or recurrent endometrial cancer at the Society of Gynecologic Oncology (SGO) annual meeting

June 21, 2023

Clarapath Secures $36M to Automate Pathology Labs with AI-Powered Robotics

What You Should Know: – Clarapath, a leading medical robotics company raises $36M in its Series B-1 round led by Northwell Ventures with participation from

July 24, 2024

Water content determination in ketones using alcohol-free reagents

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.